Related Experiment Video
Updated: Apr 25, 2026

Use of a Wireless Video-EEG System to Monitor Epileptiform Discharges Following Lateral Fluid-Percussion Induced Traumatic Brain Injury
Published on: June 21, 2019
Levetiracetam-induced neutropenia following traumatic brain injury
Kristen Bunnell1, Francesco Pucci
1Rhode Island Hospital , Providence, RI , USA.
Background:
Levetiracetam is being increasingly utilized for post-traumatic brain injury seizure prophylaxis, in part because of its more favourable adverse effect profile compared to other anti-epileptics. This report highlights an unusual, clinically significant adverse drug reaction attributed to levetiracetam use in a patient with blunt traumatic brain injury.
Methods:
This study describes a case of isolated neutropenia associated with levetiracetam in a 52-year-old man with traumatic brain injury.
Results:
The patient developed neutropenia on day 3 of therapy with levetiracetam, with an absolute neutrophil count nadir of 200. There were no other medications that may have been implicated in the development of this haematological toxicity. Neutropenia rapidly resolved upon cessation of levetiracetam therapy.
Conclusions:
Clinicians should be aware of potentially serious adverse reactions associated with levetiracetam in patients with neurological injury.
Related Concept Videos
Traumatic Brain Injury l: Introduction
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Encephalitis l: Introduction
Hepatic Encephalopathy
Drug Toxicity: Risk factors
Acute Kidney Injury I: Introduction

